{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:34Z","timestamp":1790763034019,"version":"4.1.0"},"reference-count":307,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40264-016-0435-8","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T09:22:02Z","timestamp":1465636922000},"page":"903-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects"],"prefix":"10.1007","volume":"39","author":[{"given":"Irma","family":"Convertino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Capogrosso","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Galiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Mantarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Antonioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Blandizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tuccori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"issue":"8","key":"435_CR1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/bdra.23043","volume":"94","author":"JM Friedman","year":"2012","unstructured":"Friedman JM. ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects. Birth Defects Res Part A Clin Mol Teratol. 2012;94(8):670\u20136.","journal-title":"Birth Defects Res Part A Clin Mol Teratol."},{"issue":"2","key":"435_CR2","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","volume":"134","author":"P Kocherlakota","year":"2014","unstructured":"Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014;134(2):e547\u201361.","journal-title":"Pediatrics"},{"issue":"9237","key":"435_CR3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139.","journal-title":"Lancet"},{"issue":"1","key":"435_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14740338.2011.584531","volume":"11","author":"V Fabiano","year":"2012","unstructured":"Fabiano V, Mameli C, Zuccotti GV. Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future. Expert Opinion Drug Saf. 2012;11(1):95\u2013105.","journal-title":"Expert Opinion Drug Saf."},{"issue":"1","key":"435_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ftd.0000187973.02624.67","volume":"28","author":"G Koren","year":"2006","unstructured":"Koren G. A new indication for therapeutic drug monitoring in the neonate. Ther Drug Monit. 2006;28(1):1.","journal-title":"Ther Drug Monit"},{"key":"435_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ypmed.2015.07.017","volume":"80","author":"HE Jones","year":"2015","unstructured":"Jones HE, Fielder A. Neonatal abstinence syndrome: Historical perspective, current focus, future directions. Prev Med. 2015;80:12\u20137.","journal-title":"Prev Med"},{"issue":"1","key":"435_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/archdischild-2015-309566","volume":"101","author":"K Allegaert","year":"2016","unstructured":"Allegaert K, van den Anker JN. Neonatal withdrawal syndrome: reaching epidemic proportions across the globe. Arch Dis Child Fetal Neonatal Ed. 2016;101(1):2\u20133.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"435_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1701-2163(16)34157-3","volume":"31","author":"G Koren","year":"2009","unstructured":"Koren G, Finkelstein Y, Matsui D, Berkovich M. Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin\/norepinephrine reuptake inhibitors. J Obstet Gynecol Can. 2009;31(4):348\u201350.","journal-title":"J Obstet Gynecol Can"},{"issue":"10","key":"435_CR9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/14767050802255488","volume":"21","author":"AE Jordan","year":"2008","unstructured":"Jordan AE, Jackson GL, Deardorff D, Shivakumar G, McIntire DD, Dashe JS. Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome. J Matern Fetal Neonatal Med. 2008;21(10):745\u201351.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"5","key":"435_CR10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.semperi.2008.08.001","volume":"32","author":"J Belik","year":"2008","unstructured":"Belik J. Fetal and neonatal effects of maternal drug treatment for depression. Semin Perinatol. 2008;32(5):350\u20134.","journal-title":"Semin Perinatol"},{"issue":"1","key":"435_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.genhosppsych.2013.08.002","volume":"36","author":"H Huang","year":"2014","unstructured":"Huang H, Coleman S, Bridge JA, Yonkers K, Katon W. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry. 2014;36(1):13\u20138.","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"435_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1891\/0730-0832.22.4.15","volume":"22","author":"CM Greene","year":"2003","unstructured":"Greene CM, Goodman MH. Neonatal abstinence syndrome: strategies for care of the drug-exposed infant. Neonatal netw NN. 2003;22(4):15\u201325.","journal-title":"Neonatal netw NN."},{"issue":"18","key":"435_CR13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","volume":"307","author":"SW Patrick","year":"2012","unstructured":"Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009. JAMA. 2012;307(18):1934\u201340.","journal-title":"JAMA"},{"issue":"22","key":"435_CR14","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","volume":"372","author":"VN Tolia","year":"2015","unstructured":"Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing incidence of the neonatal abstinence syndrome in US neonatal ICUs. N Engl J Med. 2015;372(22):2118\u201326.","journal-title":"N Engl J Med"},{"issue":"1","key":"435_CR15","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.9778\/cmajo.20140065","volume":"3","author":"SD Turner","year":"2015","unstructured":"Turner SD, Gomes T, Camacho X, Yao Z, Guttmann A, Mamdani MM, et al. Neonatal opioid withdrawal and antenatal opioid prescribing. CMAJ Open. 2015;3(1):E55\u201361.","journal-title":"CMAJ Open."},{"issue":"5","key":"435_CR16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2125.2008.03102.x","volume":"65","author":"A Engeland","year":"2008","unstructured":"Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol. 2008;65(5):653\u201360.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"435_CR17","first-page":"125","volume":"64","author":"MD Warren","year":"2015","unstructured":"Warren MD, Miller AM, Traylor J, Bauer A, Patrick SW. Implementation of a statewide surveillance system for neonatal abstinence syndrome\u2014Tennessee, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(5):125\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"435_CR18","first-page":"h2102","volume":"350","author":"RJ Desai","year":"2015","unstructured":"Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ (Clin Res ed). 2015;350:h2102.","journal-title":"BMJ (Clin Res ed)."},{"issue":"24","key":"435_CR19","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320\u201331.","journal-title":"N Engl J Med."},{"issue":"2","key":"435_CR20","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","volume":"129","author":"ML Hudak","year":"2012","unstructured":"Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540\u201360.","journal-title":"Pediatrics"},{"issue":"6","key":"435_CR21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3476(05)82214-0","volume":"118","author":"TM Doberczak","year":"1991","unstructured":"Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr. 1991;118(6):933\u20137.","journal-title":"J Pediatr."},{"issue":"3","key":"435_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1479-828X.2010.01168.x","volume":"50","author":"AJ Liu","year":"2010","unstructured":"Liu AJ, Jones MP, Murray H, Cook CM, Nanan R. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy. Aust N Z J Obstet Gynaecol. 2010;50(3):253\u20138.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"435_CR23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000381670","volume":"21","author":"GK Welle-Strand","year":"2015","unstructured":"Welle-Strand GK, Skurtveit S, Tanum L, Waal H, Bakstad B, Bjarko L, et al. Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996\u20132009. Eur Addict Res. 2015;21(5):253\u201361.","journal-title":"Eur Addict Res"},{"issue":"4","key":"435_CR24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/AOG.0b013e3182a6643c","volume":"122","author":"MM Yazdy","year":"2013","unstructured":"Yazdy MM, Mitchell AA, Tinker SC, Parker SE, Werler MM. Periconceptional use of opioids and the risk of neural tube defects. Obstet Gynecol. 2013;122(4):838\u201344.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"435_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.devbrainres.2005.06.012","volume":"159","author":"S Nasiraei-Moghadam","year":"2005","unstructured":"Nasiraei-Moghadam S, Sahraei H, Bahadoran H, Sadooghi M, Salimi SH, Kaka GR, et al. Effects of maternal oral morphine consumption on neural tube development in Wistar rats. Brain Res Dev Brain Res. 2005;159(1):12\u20137.","journal-title":"Brain Res Dev Brain Res"},{"key":"435_CR26","doi-asserted-by":"crossref","unstructured":"Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4):314.e1\u201311.","DOI":"10.1016\/j.ajog.2010.12.039"},{"issue":"11","key":"435_CR27","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00431-015-2562-0","volume":"174","author":"K Kivisto","year":"2015","unstructured":"Kivisto K, Tupola S, Kivitie-Kallio S. Prenatally buprenorphine-exposed children: health to 3 years of age. Eur J Pediatr. 2015;174(11):1525\u201333.","journal-title":"Eur J Pediatr"},{"issue":"1\u20132","key":"435_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.04.006","volume":"104","author":"A Fodor","year":"2014","unstructured":"Fodor A, Timar J, Zelena D. Behavioral effects of perinatal opioid exposure. Life Sci. 2014;104(1\u20132):1\u20138.","journal-title":"Life Sci"},{"issue":"12","key":"435_CR29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/jp.2014.111","volume":"34","author":"Q Yuan","year":"2014","unstructured":"Yuan Q, Rubic M, Seah J, Rae C, Wright IM, Kaltenbach K, et al. Do maternal opioids reduce neonatal regional brain volumes? A pilot study. J Perinatol. 2014;34(12):909\u201313.","journal-title":"J Perinatol."},{"issue":"7","key":"435_CR30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0929-693X(96)81235-8","volume":"2","author":"S Baglin","year":"1995","unstructured":"Baglin S, Avenel S, Renaud C, Bavoux F, Francoual C, Badoual J. Withdrawal syndrome in a newborn infant born to an addicted mother receiving methadone [in French]. Arch Pediatr. 1995;2(7):702\u20133.","journal-title":"Arch Pediatr"},{"issue":"3","key":"435_CR31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.arcped.2010.12.003","volume":"18","author":"S Dahan","year":"2011","unstructured":"Dahan S, Elefant E, Girard I, Azcona B, Champion V, Mitanchez D. Neonatal seizures, buprenorphine abstinence syndrome, and substitutive treatment with morphine [in French]. Arch Pediatr. 2011;18(3):287\u201390.","journal-title":"Arch Pediatr"},{"issue":"6","key":"435_CR32","first-page":"348","volume":"5","author":"GS Hagopian","year":"1996","unstructured":"Hagopian GS, Wolfe HM, Sokol RJ, Ager JW, Wardell JN, Cepeda EE. Neonatal outcome following methadone exposure in utero. J Matern Fetal Med. 1996;5(6):348\u201354.","journal-title":"J Matern Fetal Med."},{"issue":"2","key":"435_CR33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0929-693X(97)86842-X","volume":"5","author":"F Herve","year":"1998","unstructured":"Herve F, Quenum S. Buprenorphine (subutex) and neonatal withdrawal syndrome [in French]. Arch Pediatr. 1998;5(2):206\u20137.","journal-title":"Arch Pediatr"},{"issue":"2","key":"435_CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1360-0443.2003.00600.x","volume":"99","author":"I Lacroix","year":"2004","unstructured":"Lacroix I, Berrebi A, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction (Abingdon, England). 2004;99(2):209\u201314.","journal-title":"Addiction (Abingdon, England)."},{"issue":"11","key":"435_CR35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1055\/s-0035-1549218","volume":"32","author":"WF Liu","year":"2015","unstructured":"Liu WF, Singh K, Faisal M, Li S. Maternal methadone treatment and neonatal abstinence syndrome. Am J Perinatol. 2015;32(11):1078\u201386.","journal-title":"Am J Perinatol"},{"issue":"2","key":"435_CR36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1515\/jpme.1990.18.2.111","volume":"18","author":"U Maas","year":"1990","unstructured":"Maas U, Kattner E, Weingart-Jesse B, Schafer A, Obladen M. Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med. 1990;18(2):111\u20138.","journal-title":"J Perinat Med"},{"issue":"4","key":"435_CR37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/S2040174412000190","volume":"3","author":"AL Gordon","year":"2012","unstructured":"Gordon AL, Lopatko OV, Haslam RR, Stacey H, Pearson V, Woods A, et al. Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants. J Dev Orig Health Dis. 2012;3(4):262\u201370.","journal-title":"J Dev Orig Health Dis."},{"issue":"Suppl 1","key":"435_CR38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1360-0443.2012.04040.x","volume":"107","author":"MG Coyle","year":"2012","unstructured":"Coyle MG, Salisbury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, et al. Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction (Abingdon, England). 2012;107(Suppl 1):63\u201373.","journal-title":"Addiction (Abingdon, England)."},{"issue":"2","key":"435_CR39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/S0002-9378(03)00520-9","volume":"189","author":"V Berghella","year":"2003","unstructured":"Berghella V, Lim PJ, Hill MK, Cherpes J, Chennat J, Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol. 2003;189(2):312\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"435_CR40","unstructured":"Seligman NS, Almario CV, Hayes EJ, Dysart KC, Berghella V, Baxter JK. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. J Pediatrics. 2010;157(3):428\u201333, 33.e1."},{"key":"435_CR41","doi-asserted-by":"crossref","unstructured":"Cleary BJ, Donnelly J, Strawbridge J, Gallagher PJ, Fahey T, Clarke M et al. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction (Abingdon, England). 2010;105(12):2071\u201384.","DOI":"10.1111\/j.1360-0443.2010.03120.x"},{"issue":"3","key":"435_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000441220","volume":"22","author":"AB O\u2019Connor","year":"2016","unstructured":"O\u2019Connor AB, O\u2019Brien L, Alto WA. Maternal buprenorphine dose at delivery and its relationship to neonatal outcomes. Eur Addict Res. 2016;22(3):127\u201330.","journal-title":"Eur Addict Res"},{"key":"435_CR43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","volume":"134","author":"HE Jones","year":"2014","unstructured":"Jones HE, Dengler E, Garrison A, O\u2019Grady KE, Seashore C, Horton E, et al. Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy. Drug Alcohol Depend. 2014;134:414\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"435_CR44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","volume":"82","author":"C Lejeune","year":"2006","unstructured":"Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution. Drug Alcohol Depend. 2006;82(3):250\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"435_CR45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/ADM.0000000000000099","volume":"9","author":"JJ McCarthy","year":"2015","unstructured":"McCarthy JJ, Leamon MH, Willits NH, Salo R. The effect of methadone dose regimen on neonatal abstinence syndrome. J Addict Med. 2015;9(2):105\u201310.","journal-title":"J Addict Med."},{"issue":"3","key":"435_CR46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1034\/j.1399-6576.2000.440323.x","volume":"44","author":"R Sabatowski","year":"2000","unstructured":"Sabatowski R, Radbruch L, Grond S, Gohring UJ. Treatment of severe low back pain with opioids during pregnancy in a patient with incomplete tetraplegia. Acta Anaesthesiol Scand. 2000;44(3):348\u201350.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"435_CR47","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1136\/fn.76.1.F59","volume":"76","author":"K Khan","year":"1997","unstructured":"Khan K, Chang J. Neonatal abstinence syndrome due to codeine. Arch Dis Child Fetal Neonatal Ed. 1997;76(1):F59\u201360.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"435_CR48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1542\/peds.65.1.159","volume":"65","author":"HH Mangurten","year":"1980","unstructured":"Mangurten HH, Benawra R. Neonatal codeine withdrawal in infants of nonaddicted mothers. Pediatrics. 1980;65(1):159\u201360.","journal-title":"Pediatrics"},{"issue":"4","key":"435_CR49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1542\/peds.36.4.635","volume":"36","author":"G Leeuwen Van","year":"1965","unstructured":"Van Leeuwen G, Guthrie R, Stange F. Narcotic withdrawal reaction in a newborn infant due to codeine. Pediatrics. 1965;36(4):635\u20136.","journal-title":"Pediatrics"},{"issue":"5","key":"435_CR50","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1093\/pch\/17.5.e40","volume":"17","author":"V Nair","year":"2012","unstructured":"Nair V, Soraisham AS, Akierman A. Neonatal withdrawal syndrome due to maternal codeine use. Paediatr Child Health. 2012;17(5):e40\u20131.","journal-title":"Paediatr Child Health."},{"issue":"7","key":"435_CR51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/0009922807300795","volume":"46","author":"EW Reynolds","year":"2007","unstructured":"Reynolds EW, Riel-Romero RM, Bada HS. Neonatal abstinence syndrome and cerebral infarction following maternal codeine use during pregnancy. Clin Pediatr. 2007;46(7):639\u201345.","journal-title":"Clin Pediatr"},{"issue":"6","key":"435_CR52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1515\/jpm.2010.102","volume":"38","author":"S Hartenstein","year":"2010","unstructured":"Hartenstein S, Proquitte H, Bauer S, Bamberg C, Roehr CC. Neonatal abstinence syndrome (NAS) after intrauterine exposure to tramadol. J Perinat Med. 2010;38(6):695\u20136.","journal-title":"J Perinat Med"},{"issue":"7\u20138","key":"435_CR53","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1345\/aph.1M758","volume":"44","author":"K O\u2019Mara","year":"2010","unstructured":"O\u2019Mara K, Gal P, Davanzo C. Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol. Ann Pharmacother. 2010;44(7\u20138):1342\u20134.","journal-title":"Ann Pharmacother."},{"issue":"4","key":"435_CR54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-008-0598-z","volume":"65","author":"C Willaschek","year":"2009","unstructured":"Willaschek C, Wolter E, Buchhorn R. Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother. Eur J Clin Pharmacol. 2009;65(4):429\u201330.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"435_CR55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002280050356","volume":"53","author":"FP Meyer","year":"1997","unstructured":"Meyer FP, Rimasch H, Blaha B, Banditt P. Tramadol withdrawal in a neonate. Eur J Clin Pharmacol. 1997;53(2):159\u201360.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"435_CR56","first-page":"A5610","volume":"157","author":"D Wit de","year":"2013","unstructured":"de Wit D, Koomen-Botman I. Neonatal abstinence syndrome after maternal use of tramadol [in Dutch]. Ned Tijdschr Geneeskd. 2013;157(9):A5610.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"6","key":"435_CR57","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.55.6.882","volume":"55","author":"RB Klein","year":"1975","unstructured":"Klein RB, Blatman S, Little GA. Probable neonatal propoxyphene withdrawal: a case report. Pediatrics. 1975;55(6):882\u20134.","journal-title":"Pediatrics"},{"issue":"13","key":"435_CR58","first-page":"2084","volume":"78","author":"G Ente","year":"1978","unstructured":"Ente G, Mehra MC. Neonatal withdrawal from propoxyphene hydrochloride. N Y State J Med. 1978;78(13):2084\u20135.","journal-title":"N Y State J Med."},{"issue":"19","key":"435_CR59","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1001\/jama.1976.03260450040031","volume":"235","author":"WW Quillian 2nd","year":"1976","unstructured":"Quillian WW 2nd, Dunn CA. Neonatal drug withdrawal from propoxyphene. JAMA. 1976;235(19):2128.","journal-title":"JAMA."},{"issue":"5","key":"435_CR60","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-3476(74)80519-6","volume":"85","author":"HK Tyson","year":"1974","unstructured":"Tyson HK. Neonatal withdrawal symptoms associated with maternal use of propoxyphene hydrochloride (Darvon). J Pediatrics. 1974;85(5):684\u20135.","journal-title":"J Pediatrics."},{"issue":"4","key":"435_CR61","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1471-0528.2000.tb13282.x","volume":"107","author":"J Regan","year":"2000","unstructured":"Regan J, Chambers F, Gorman W, MacSullivan R. Neonatal abstinence syndrome due to prolonged administration of fentanyl in pregnancy. BJOG Int J Obst Gynaecol. 2000;107(4):570\u20132.","journal-title":"BJOG Int J Obst Gynaecol."},{"issue":"3","key":"435_CR62","first-page":"229","volume":"42","author":"WH Wu","year":"1988","unstructured":"Wu WH, Teng RJ, Shin HY. Neonatal pentazocine withdrawal syndrome\u2014a case report of conservative treatment. Zhonghua yi Xue Za Zhi\u00a0(Taipei). 1988;42(3):229\u201332.","journal-title":"Zhonghua yi Xue Za Zhi\u00a0(Taipei)"},{"issue":"5","key":"435_CR63","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3476(74)80536-6","volume":"85","author":"JW Scanlon","year":"1974","unstructured":"Scanlon JW. Letter: pentazocine and neonatal withdrawal symptoms. J Pediatrics. 1974;85(5):735\u20136.","journal-title":"J Pediatrics."},{"issue":"6","key":"435_CR64","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0022-3476(74)80775-4","volume":"84","author":"RL Goetz","year":"1974","unstructured":"Goetz RL, Bain RV. Neonatal withdrawal symptoms associated with maternal use of pentazocine. J Pediatrics. 1974;84(6):887\u20138.","journal-title":"J Pediatrics."},{"issue":"3","key":"435_CR65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jpeds.2014.05.040","volume":"165","author":"EM Wachman","year":"2014","unstructured":"Wachman EM, Hayes MJ, Lester BM, Terrin N, Brown MS, Nielsen DA, et al. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. J Pediatr. 2014;165(3):472\u20138.","journal-title":"J Pediatr."},{"issue":"2\u20133","key":"435_CR66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drugalcdep.2006.08.024","volume":"87","author":"N Ebner","year":"2007","unstructured":"Ebner N, Rohrmeister K, Winklbaur B, Baewert A, Jagsch R, Peternell A, et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend. 2007;87(2\u20133):131\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"2 Suppl","key":"435_CR67","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","volume":"70","author":"RE Johnson","year":"2003","unstructured":"Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70(2 Suppl):S87\u2013101.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"435_CR68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/j.semperi.2015.08.013","volume":"39","author":"MW Stover","year":"2015","unstructured":"Stover MW, Davis JM. Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol. 2015;39(7):561\u20135.","journal-title":"Semin Perinatol"},{"issue":"1","key":"435_CR69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1874473707666141015215141","volume":"7","author":"K Wolff","year":"2014","unstructured":"Wolff K, Perez-Montejano R. Opioid neonatal abstinence syndrome: controversies and implications for practice. Current Drug Abuse Rev. 2014;7(1):44\u201358.","journal-title":"Current Drug Abuse Rev."},{"issue":"1","key":"435_CR70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1940-0640-9-19","volume":"9","author":"SM Bagley","year":"2014","unstructured":"Bagley SM, Wachman EM, Holland E, Brogly SB. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract. 2014;9(1):19.","journal-title":"Addict Sci Clin Pract."},{"issue":"1","key":"435_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jp.7211427","volume":"26","author":"S Sarkar","year":"2006","unstructured":"Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol. 2006;26(1):15\u20137.","journal-title":"J Perinatol"},{"issue":"1\u20132","key":"435_CR72","first-page":"141","volume":"2","author":"LP Finnegan","year":"1975","unstructured":"Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addictive diseases. 1975;2(1\u20132):141\u201358.","journal-title":"Addictive diseases."},{"key":"435_CR73","doi-asserted-by":"crossref","unstructured":"Lipsitz PJ. A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr. 1975;14(6):592\u20134.","DOI":"10.1177\/000992287501400613"},{"issue":"2","key":"435_CR74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/00952998108999125","volume":"8","author":"M Green","year":"1981","unstructured":"Green M, Suffet F. The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse. 1981;8(2):203\u201313.","journal-title":"Am J Drug Alcohol Abuse."},{"issue":"2","key":"435_CR75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004703-199804000-00005","volume":"19","author":"W Zahorodny","year":"1998","unstructured":"Zahorodny W, Rom C, Whitney W, Giddens S, Samuel M, Maichuk G, et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr JDBP. 1998;19(2):89\u201393.","journal-title":"J Dev Behav Pediatr JDBP."},{"issue":"2","key":"435_CR76","doi-asserted-by":"crossref","first-page":"F141","DOI":"10.1136\/adc.2009.181701","volume":"96","author":"R Parikh","year":"2011","unstructured":"Parikh R, Hussain T, Holder G, Bhoyar A, Ewer AK. Maternal methadone therapy increases QTc interval in newborn infants. Arch Dis Child Fetal Neonatal Ed. 2011;96(2):F141\u20133.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"435_CR77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0022-3476(05)81554-9","volume":"123","author":"SR Kandall","year":"1993","unstructured":"Kandall SR, Gaines J, Habel L, Davidson G, Jessop D. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr. 1993;123(1):120\u20136.","journal-title":"J Pediatr."},{"issue":"11","key":"435_CR78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/jp.2011.116","volume":"31","author":"LL Bio","year":"2011","unstructured":"Bio LL, Siu A, Poon CY. Update on the pharmacologic management of neonatal abstinence syndrome. J Perinatol. 2011;31(11):692\u2013701.","journal-title":"J Perinatol"},{"issue":"3","key":"435_CR79","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0149-7634(94)90050-7","volume":"18","author":"MA Bozarth","year":"1994","unstructured":"Bozarth MA. Physical dependence produced by central morphine infusions: an anatomical mapping study. Neurosci Biobehav Rev. 1994;18(3):373\u201383.","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"435_CR80","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0028-3908(92)90051-P","volume":"31","author":"R Maldonado","year":"1992","unstructured":"Maldonado R, Negus S, Koob GF. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology. 1992;31(12):1231\u201341.","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"435_CR81","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejphar.2004.07.036","volume":"500","author":"R Przewlocki","year":"2004","unstructured":"Przewlocki R. Opioid abuse and brain gene expression. Eur J Pharmacol. 2004;500(1\u20133):331\u201349.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"435_CR82","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.pcl.2012.07.006","volume":"59","author":"WK Kraft","year":"2012","unstructured":"Kraft WK, van den Anker JN. Pharmacologic management of the opioid neonatal abstinence syndrome. Pediatr Clin North Am. 2012;59(5):1147\u201365.","journal-title":"Pediatr Clin North Am"},{"issue":"17","key":"435_CR83","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2013.3411","volume":"309","author":"EM Wachman","year":"2013","unstructured":"Wachman EM, Hayes MJ, Brown MS, Paul J, Harvey-Wilkes K, Terrin N, et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA. 2013;309(17):1821\u20137.","journal-title":"JAMA"},{"issue":"6","key":"435_CR84","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1542\/peds.2005-1561","volume":"117","author":"ME Abdel-Latif","year":"2006","unstructured":"Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics. 2006;117(6):e1163\u20139.","journal-title":"Pediatrics"},{"issue":"4","key":"435_CR85","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/ANC.0b013e318225a30c","volume":"11","author":"KA McQueen","year":"2011","unstructured":"McQueen KA, Murphy-Oikonen J, Gerlach K, Montelpare W. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Adv Neonatal Care. 2011;11(4):282\u201390.","journal-title":"Adv Neonatal Care."},{"issue":"4","key":"435_CR86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jmwh.12009","volume":"58","author":"AB O\u2019Connor","year":"2013","unstructured":"O\u2019Connor AB, Collett A, Alto WA, O\u2019Brien LM. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. J Midwifery Womens Health. 2013;58(4):383\u20138.","journal-title":"J Midwifery Womens Health."},{"key":"435_CR87","doi-asserted-by":"crossref","unstructured":"Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarko L, Ravndal E. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta paediatrica (Oslo, Norway: 1992). 2013;102(11):1060\u20136.","DOI":"10.1111\/apa.12378"},{"issue":"5","key":"435_CR88","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","volume":"116","author":"C Dryden","year":"2009","unstructured":"Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG Int J Obstet Gynaecol. 2009;116(5):665\u201371.","journal-title":"BJOG Int J Obstet Gynaecol."},{"issue":"2","key":"435_CR89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1552-6909.2011.01330.x","volume":"41","author":"UA Pritham","year":"2012","unstructured":"Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs JOGNN\/NAACOG. 2012;41(2):180\u201390.","journal-title":"J Obstet Gynecol Neonatal Nurs JOGNN\/NAACOG."},{"issue":"1","key":"435_CR90","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.2007-1182","volume":"121","author":"LM Jansson","year":"2008","unstructured":"Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. 2008;121(1):106\u201314.","journal-title":"Pediatrics"},{"key":"435_CR91","doi-asserted-by":"crossref","unstructured":"Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database Syst Rev. 2013;12:CD006318.","DOI":"10.1002\/14651858.CD006318.pub3"},{"issue":"39\u201344","key":"435_CR92","first-page":"e1","volume":"170","author":"ES Hall","year":"2016","unstructured":"Hall ES, Isemann BT, Wexelblatt SL, Meinzen-Derr J, Wiles JR, Harvey S, et al. A cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome. J Pediatr. 2016;170(39\u201344):e1.","journal-title":"J Pediatr."},{"issue":"3","key":"435_CR93","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1542\/peds.2008-0571","volume":"122","author":"WK Kraft","year":"2008","unstructured":"Kraft WK, Gibson E, Dysart K, Damle VS, Larusso JL, Greenspan JS, et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics. 2008;122(3):e601\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"435_CR94","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","volume":"5","author":"LM Jansson","year":"2009","unstructured":"Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag. 2009;5(1):47\u201355.","journal-title":"J Opioid Manag."},{"issue":"12","key":"435_CR95","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jp.2013.95","volume":"33","author":"B Surran","year":"2013","unstructured":"Surran B, Visintainer P, Chamberlain S, Kopcza K, Shah B, Singh R. Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial. J Perinatol. 2013;33(12):954\u20139.","journal-title":"J Perinatol"},{"issue":"4","key":"435_CR96","doi-asserted-by":"crossref","first-page":"F300","DOI":"10.1136\/adc.2003.033555","volume":"89","author":"L Jackson","year":"2004","unstructured":"Jackson L, Ting A, McKay S, Galea P, Skeoch C. A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):F300\u20134.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"435_CR97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.07.001","volume":"77","author":"S Langenfeld","year":"2005","unstructured":"Langenfeld S, Birkenfeld L, Herkenrath P, Muller C, Hellmich M, Theisohn M. Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops. Drug Alcohol Depend. 2005;77(1):31\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"435_CR98","doi-asserted-by":"crossref","unstructured":"Kraft WK, Dysart K, Greenspan JS, Gibson E, Kaltenbach K, Ehrlich ME. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction (Abingdon, England). 2011;106(3):574\u201380.","DOI":"10.1111\/j.1360-0443.2010.03170.x"},{"issue":"5","key":"435_CR99","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mpd.2002.123099","volume":"140","author":"MG Coyle","year":"2002","unstructured":"Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr. 2002;140(5):561\u20134.","journal-title":"J Pediatr."},{"issue":"5","key":"435_CR100","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1542\/peds.2008-0978","volume":"123","author":"AG Agthe","year":"2009","unstructured":"Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L, et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics. 2009;123(5):e849\u201356.","journal-title":"Pediatrics"},{"issue":"19","key":"435_CR101","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","volume":"293","author":"EL Moses-Kolko","year":"2005","unstructured":"Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005;293(19):2372\u201383.","journal-title":"JAMA"},{"key":"435_CR102","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2147\/NDT.S36394","volume":"9","author":"N Kieviet","year":"2013","unstructured":"Kieviet N, Dolman KM, Honig A. The use of psychotropic medication during pregnancy: how about the newborn? Neuropsychiatr Dis Treat. 2013;9:1257\u201366.","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"3","key":"435_CR103","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/GRF.0b013e3181b52e20","volume":"52","author":"JL Payne","year":"2009","unstructured":"Payne JL, Meltzer-Brody S. Antidepressant use during pregnancy: current controversies and treatment strategies. Clin Obstet Gynecol. 2009;52(3):469\u201382.","journal-title":"Clin Obstet Gynecol"},{"key":"435_CR104","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2013.00073","volume":"7","author":"JD Olivier","year":"2013","unstructured":"Olivier JD, Akerud H, Kaihola H, Pawluski JL, Skalkidou A, Hogberg U, et al. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci. 2013;7:73.","journal-title":"Front Cell Neurosci."},{"issue":"9458","key":"435_CR105","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)70271-3","volume":"365","author":"EJ Sanz","year":"2005","unstructured":"Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005;365(9458):482\u20137.","journal-title":"Lancet"},{"issue":"10","key":"435_CR106","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1345\/aph.1H116","volume":"40","author":"GM Thormahlen","year":"2006","unstructured":"Thormahlen GM. Paroxetine use during pregnancy: is it safe? Ann Pharmacother. 2006;40(10):1834\u20137.","journal-title":"Ann Pharmacother."},{"issue":"2","key":"435_CR107","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","volume":"65","author":"TF Oberlander","year":"2004","unstructured":"Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry. 2004;65(2):230\u20137.","journal-title":"J Clin Psychiatry."},{"issue":"3\u20134","key":"435_CR108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s002280050357","volume":"53","author":"MM Stahl","year":"1997","unstructured":"Stahl MM, Lindquist M, Pettersson M, Edwards IR, Sanderson JH, Taylor NF, et al. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol. 1997;53(3\u20134):163\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"435_CR109","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2011.04072.x","volume":"73","author":"PG Horst ter","year":"2012","unstructured":"ter Horst PG, van der Linde S, Smit JP, den Boon J, van Lingen RA, Jansman FG, et al. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br J Clin Pharmacol. 2012;73(2):295\u2013302.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"435_CR110","doi-asserted-by":"crossref","first-page":"e111327","DOI":"10.1371\/journal.pone.0111327","volume":"9","author":"L Forsberg","year":"2014","unstructured":"Forsberg L, Naver L, Gustafsson LL, Wide K. Neonatal adaptation in infants prenatally exposed to antidepressants\u2013clinical monitoring using Neonatal Abstinence Score. PLoS ONE. 2014;9(11):e111327.","journal-title":"PLoS ONE"},{"issue":"4","key":"435_CR111","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.11622\/smedj.2014061","volume":"55","author":"A Ansary","year":"2014","unstructured":"Ansary A, Ibhanesebhor S, Manjunatha C. Myoclonic seizures in a preterm baby: is this a presentation of venlafaxine withdrawal? Singap Med J. 2014;55(4):e57\u20139.","journal-title":"Singap Med J"},{"issue":"5","key":"435_CR112","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1176\/appi.ajp.2008.07071194","volume":"165","author":"R Eyal","year":"2008","unstructured":"Eyal R, Yaeger D. Poor neonatal adaptation after in utero exposure to duloxetine. Am J Psychiatry. 2008;165(5):651.","journal-title":"Am J Psychiatry."},{"issue":"10","key":"435_CR113","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/0009922812450509","volume":"52","author":"NA Abdy","year":"2013","unstructured":"Abdy NA, Gerhart K. Duloxetine withdrawal syndrome in a newborn. Clin Pediatr. 2013;52(10):976\u20137.","journal-title":"Clin Pediatr"},{"issue":"12","key":"435_CR114","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/14767050802266899","volume":"21","author":"F Alehan","year":"2008","unstructured":"Alehan F, Saygi S, Tarcan A, Gurakan B. Prolonged neonatal complications after in utero exposure to fluoxetine. J Matern Fetal Neonatal medicine. 2008;21(12):921\u20133.","journal-title":"J Matern Fetal Neonatal medicine."},{"issue":"1","key":"435_CR115","first-page":"66","volume":"43","author":"AT Anbu","year":"2006","unstructured":"Anbu AT, Theodore A. Fluoxetine withdrawal syndrome in the newborn. Indian Pediatr. 2006;43(1):66\u20139.","journal-title":"Indian Pediatr"},{"key":"435_CR116","first-page":"1333","volume":"9","author":"C Bellantuono","year":"2013","unstructured":"Bellantuono C, Bozzi F, Orsolini L. Safety of escitalopram in pregnancy: a case series. Neuropsychiatr Dis Treat. 2013;9:1333\u20137.","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"30","key":"435_CR117","first-page":"1473","volume":"136","author":"JB Boringa","year":"1992","unstructured":"Boringa JB, de Jong GM, Touw DJ. Neonatal withdrawal symptoms following the use of clomipramine during pregnancy [in Dutch]. Ned Tijdschr Geneeskd. 1992;136(30):1473\u20135.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"11","key":"435_CR118","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","volume":"156","author":"AM Costei","year":"2002","unstructured":"Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med. 2002;156(11):1129\u201332.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"435_CR119","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.1462","volume":"16","author":"RL Davis","year":"2007","unstructured":"Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf. 2007;16(10):1086\u201394.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"28","key":"435_CR120","first-page":"1370","volume":"147","author":"RA Moor de","year":"2003","unstructured":"de Moor RA, Mourad L, ter Haar J, Egberts AC. Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy [in Dutch]. Ned Tijdschr Geneeskd. 2003;147(28):1370\u20132.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"435_CR121","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000350506","volume":"104","author":"L Leibovitch","year":"2013","unstructured":"Leibovitch L, Rymer-Haskel N, Schushan-Eisen I, Kuint J, Strauss T, Maayan-Metzger A. Short-term neonatal outcome among term infants after in utero exposure to serotonin reuptake inhibitors. Neonatology. 2013;104(1):65\u201370.","journal-title":"Neonatology."},{"issue":"2","key":"435_CR122","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","volume":"160","author":"R Levinson-Castiel","year":"2006","unstructured":"Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160(2):173\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"435_CR123","doi-asserted-by":"crossref","unstructured":"Nordeng H, Lindemann R, Perminov KV, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta paediatrica (Oslo, Norway: 1992). 2001;90(3):288\u201391.","DOI":"10.1080\/080352501300067596"},{"issue":"6","key":"435_CR124","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.jp.7211115","volume":"24","author":"RP Santos","year":"2004","unstructured":"Santos RP, Pergolizzi JJ. Transient neonatal jitteriness due to maternal use of sertraline (Zoloft). J Perinatol. 2004;24(6):392\u20134.","journal-title":"J Perinatol"},{"issue":"6332","key":"435_CR125","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1136\/bmj.284.6332.1837-a","volume":"284","author":"L Cowe","year":"1982","unstructured":"Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J (Clin Res Ed). 1982;284(6332):1837\u20138.","journal-title":"Br Med J (Clin Res Ed)."},{"key":"435_CR126","doi-asserted-by":"crossref","unstructured":"Haddad PM, Pal BR, Clarke P, Wieck A, Sridhiran S. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome? J Psychopharmacol (Oxf Engl). 2005;19(5):554\u20137.","DOI":"10.1177\/0269881105056554"},{"issue":"11","key":"435_CR127","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1440-1754.2006.00962.x","volume":"42","author":"RK Pakalapati","year":"2006","unstructured":"Pakalapati RK, Bolisetty S, Austin MP, Oei J. Neonatal seizures from in utero venlafaxine exposure. J Paediatr Child Health. 2006;42(11):737\u20138.","journal-title":"J Paediatr Child Health"},{"key":"435_CR128","doi-asserted-by":"publisher","unstructured":"Pogliani L, Schneider L, Dilillo D, Penagini F, Zuccotti GV. Paroxetine and neonatal withdrawal syndrome. BMJ Case Rep. 2010;2010. pii:bcr1220092528. doi: 10.1136\/bcr.12.2009.2528 .","DOI":"10.1136\/bcr.12.2009.2528"},{"issue":"4","key":"435_CR129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archpedi.158.4.312","volume":"158","author":"B Kallen","year":"2004","unstructured":"Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004;158(4):312\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"10","key":"435_CR130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00431-003-1293-9","volume":"162","author":"S Jaiswal","year":"2003","unstructured":"Jaiswal S, Coombs RC, Isbister GK. Paroxetine withdrawal in a neonate with historical and laboratory confirmation. Eur J Pediatr. 2003;162(10):723\u20134.","journal-title":"Eur J Pediatr"},{"issue":"8","key":"435_CR131","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/sj.jp.7211772","volume":"27","author":"KL Murray","year":"2007","unstructured":"Murray KL, Miller KM, Pearson DL. Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine. J Perinatol. 2007;27(8):517\u20138.","journal-title":"J Perinatol"},{"issue":"4","key":"435_CR132","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.4088\/JCP.12r07967","volume":"74","author":"S Grigoriadis","year":"2013","unstructured":"Grigoriadis S, VonderPorten EH, Mamisashvili L, Eady A, Tomlinson G, Dennis CL, et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e309\u201320.","journal-title":"J Clin Psychiatry."},{"issue":"12","key":"435_CR133","doi-asserted-by":"crossref","first-page":"e1423","DOI":"10.4088\/JCP.14f09631","volume":"75","author":"C Andrade","year":"2014","unstructured":"Andrade C. The safety of duloxetine during pregnancy and lactation. J Clin Psychiatry. 2014;75(12):e1423\u20137.","journal-title":"J Clin Psychiatry."},{"issue":"4","key":"435_CR134","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/OGX.0b013e3181676be8","volume":"63","author":"PG Horst Ter","year":"2008","unstructured":"Ter Horst PG, Jansman FG, van Lingen RA, Smit P, Jong-van den Berg LT, Brouwers JR. Pharmacological aspects of neonatal antidepressant withdrawal. Obstet Gynecol Surv. 2008;63(4):267\u201379.","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"435_CR135","first-page":"107","volume":"45","author":"G Klinger","year":"2008","unstructured":"Klinger G, Merlob P. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Isr J Psychiatry Relat Sci. 2008;45(2):107\u201313.","journal-title":"Isr J Psychiatry Relat Sci."},{"issue":"2","key":"435_CR136","doi-asserted-by":"crossref","first-page":"F153","DOI":"10.1136\/adc.2004.066431","volume":"91","author":"P Bot","year":"2006","unstructured":"Bot P, Semmekrot BA, van der Stappen J. Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy. Arch Dis Child Fetal Neonatal Ed. 2006;91(2):F153.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"435_CR137","doi-asserted-by":"crossref","unstructured":"Eleftheriou G, Butera R, Cotti Cottini F, Bonati M, Farina M. Neonatal toxicity following maternal citalopram treatment. Fetal Pediatr Pathol. 2013;32(5):362\u20136.","DOI":"10.3109\/15513815.2013.768743"},{"issue":"7","key":"435_CR138","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","volume":"60","author":"K Laine","year":"2003","unstructured":"Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60(7):720\u20136.","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"435_CR139","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1503\/cmaj.1041100","volume":"172","author":"G Koren","year":"2005","unstructured":"Koren G, Matsui D, Einarson A, Knoppert D, Steiner M. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? CMAJ. 2005;172(11):1457\u20139.","journal-title":"CMAJ"},{"issue":"8","key":"435_CR140","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","volume":"63","author":"TF Oberlander","year":"2006","unstructured":"Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006;63(8):898\u2013906.","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"435_CR141","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jp.2010.211","volume":"31","author":"G Klinger","year":"2011","unstructured":"Klinger G, Frankenthal D, Merlob P, Diamond G, Sirota L, Levinson-Castiel R, et al. Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. J Perinatol. 2011;31(9):615\u201320.","journal-title":"J Perinatol"},{"issue":"3","key":"435_CR142","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","volume":"42","author":"J Rampono","year":"2009","unstructured":"Rampono J, Simmer K, Ilett KF, Hackett LP, Doherty DA, Elliot R, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry. 2009;42(3):95\u2013100.","journal-title":"Pharmacopsychiatry."},{"issue":"3","key":"435_CR143","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/S1461145704004286","volume":"7","author":"J Rampono","year":"2004","unstructured":"Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol. 2004;7(3):329\u201334.","journal-title":"Int J Neuropsychopharmacol."},{"issue":"9","key":"435_CR144","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1471-0528.2002.01467.x","volume":"109","author":"T Heikkine","year":"2002","unstructured":"Heikkine T, Ekblad U, Laine K. Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta. BJOG Int J Obstetr Gynaecol. 2002;109(9):1003\u20138.","journal-title":"BJOG Int J Obstetr Gynaecol."},{"issue":"5","key":"435_CR145","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004714-199610000-00003","volume":"16","author":"NJ Coupland","year":"1996","unstructured":"Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol. 1996;16(5):356\u201362.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"435_CR146","first-page":"449","volume":"74","author":"CH Warner","year":"2006","unstructured":"Warner CH, Bobo W, Warner C, Reid S, Rachal J. Antidepressant discontinuation syndrome. Am Fam Physician. 2006;74(3):449\u201356.","journal-title":"Am Fam Physician"},{"issue":"6","key":"435_CR147","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0447.2009.01490.x","volume":"121","author":"W Warburton","year":"2010","unstructured":"Warburton W, Hertzman C, Oberlander TF. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand. 2010;121(6):471\u20139.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"435_CR148","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.2006-2133","volume":"119","author":"E Ferreira","year":"2007","unstructured":"Ferreira E, Carceller AM, Agogue C, Martin BZ, St-Andre M, Francoeur D, et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics. 2007;119(1):52\u20139.","journal-title":"Pediatrics"},{"issue":"9","key":"435_CR149","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/pch\/16.9.562","volume":"16","author":"AL Jefferies","year":"2011","unstructured":"Jefferies AL. Selective serotonin reuptake inhibitors in pregnancy and infant outcomes. Paediatr Child Health. 2011;16(9):562\u20133.","journal-title":"Paediatr Child Health."},{"issue":"Pt 1","key":"435_CR150","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.clinthera.2009.07.009","volume":"31","author":"M Tuccori","year":"2009","unstructured":"Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, et al. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic\/noradrenergic antidepressants during pregnancy: a review. Clin Ther. 2009;31(Pt 1):1426\u201353.","journal-title":"Clin Ther"},{"key":"435_CR151","doi-asserted-by":"publisher","unstructured":"Morris R, Matthes J. Serotonin syndrome in a breast-fed neonate. BMJ Case Rep. 2015;2015. pii:bcr2015209418. doi: 10.1136\/bcr-2015-209418 .","DOI":"10.1136\/bcr-2015-209418"},{"issue":"3","key":"435_CR152","first-page":"162","volume":"57","author":"M Ahmed","year":"2007","unstructured":"Ahmed M, Parameshwaran A, Swamy P. Neonatal convulsions secondary to paroxetine withdrawal. J Pak Med Assoc. 2007;57(3):162.","journal-title":"J Pak Med Assoc"},{"issue":"10","key":"435_CR153","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0006-3223(01)01197-0","volume":"50","author":"V Hendrick","year":"2001","unstructured":"Hendrick V, Stowe ZN, Altshuler LL, Mintz J, Hwang S, Hostetter A, et al. Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol Psychiatry. 2001;50(10):775\u201382.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"435_CR154","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00737-011-0215-5","volume":"14","author":"PM Boyce","year":"2011","unstructured":"Boyce PM, Hackett LP, Ilett KF. Duloxetine transfer across the placenta during pregnancy and into milk during lactation. Arch Womens Mental Health. 2011;14(2):169\u201372.","journal-title":"Arch Womens Mental Health."},{"issue":"11","key":"435_CR155","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1345\/aph.1M317","volume":"43","author":"GG Briggs","year":"2009","unstructured":"Briggs GG, Ambrose PJ, Ilett KF, Hackett LP, Nageotte MP, Padilla G. Use of duloxetine in pregnancy and lactation. Ann Pharmacother. 2009;43(11):1898\u2013902.","journal-title":"Ann Pharmacother."},{"issue":"2","key":"435_CR156","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4274\/jcrpe.v2i2.92","volume":"2","author":"D Coban","year":"2010","unstructured":"Coban D, Kurtoglu S, Akin MA, Akcakus M, Gunes T. Neonatal episodic hypoglycemia: a finding of valproic acid withdrawal. J Clin Res Pediatr Endocrinol. 2010;2(2):92\u20134.","journal-title":"J Clin Res Pediatr Endocrinol."},{"issue":"Suppl 2","key":"435_CR157","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00508-006-0539-8","volume":"118","author":"S Burja","year":"2006","unstructured":"Burja S, Rakovec-Felser Z, Treiber M, Hajdinjak D, Gajsek-Marchetti M. The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study. Wien Klin Wochenschr. 2006;118(Suppl 2):12\u20136.","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"435_CR158","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/seiz.2000.0392","volume":"9","author":"JC Dean","year":"2000","unstructured":"Dean JC, Moore SJ, Turnpenny PD. Developing diagnostic criteria for the fetal anticonvulsant syndromes. Seizure. 2000;9(3):233\u20134.","journal-title":"Seizure."},{"issue":"4","key":"435_CR159","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jmg.39.4.251","volume":"39","author":"JC Dean","year":"2002","unstructured":"Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet. 2002;39(4):251\u20139.","journal-title":"J Med Genet"},{"issue":"13","key":"435_CR160","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-0528.2009.02354.x","volume":"116","author":"I Borthen","year":"2009","unstructured":"Borthen I, Eide MG, Veiby G, Daltveit AK, Gilhus NE. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG Int J Obstetr Gynaecol. 2009;116(13):1736\u201342.","journal-title":"BJOG Int J Obstetr Gynaecol."},{"key":"435_CR161","first-page":"e89","volume":"18","author":"K Brosh","year":"2011","unstructured":"Brosh K, Matok I, Sheiner E, Koren G, Wiznitzer A, Gorodischer R et al. Teratogenic determinants of first-trimester exposure to antiepileptic medications. J Popul Ther Clin Pharmacol. 2011;18:e89\u201398.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"435_CR162","first-page":"g5159","volume":"349","author":"BH Bech","year":"2014","unstructured":"Bech BH, Kjaersgaard MI, Pedersen HS, Howards PP, Sorensen MJ, Olsen J, et al. Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study. BMJ (Clin Research Ed). 2014;349:g5159.","journal-title":"BMJ (Clin Research Ed)."},{"issue":"6","key":"435_CR163","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/ppe.12004","volume":"26","author":"WV Bobo","year":"2012","unstructured":"Bobo WV, Davis RL, Toh S, Li DK, Andrade SE, Cheetham TC, et al. Trends in the use of antiepileptic drugs among pregnant women in the US, 2001\u20132007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinat Epidemiol. 2012;26(6):578\u201388.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"9","key":"435_CR164","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/WNL.0000000000001304","volume":"84","author":"X Wen","year":"2015","unstructured":"Wen X, Meador KJ, Hartzema A. Antiepileptic drug use by pregnant women enrolled in Florida Medicaid. Neurology. 2015;84(9):944\u201350.","journal-title":"Neurology."},{"key":"435_CR165","doi-asserted-by":"crossref","unstructured":"Utilization of antiepileptic drugs during pregnancy: comparative patterns in 38 countries based on data from the EURAP registry. Epilepsia. 2009;50(10):2305\u20139.","DOI":"10.1111\/j.1528-1167.2009.02093.x"},{"issue":"2","key":"435_CR166","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2009.01260.x","volume":"121","author":"FJ Vajda","year":"2010","unstructured":"Vajda FJ, Hollingworth S, Graham J, Hitchcock AA, O\u2019Brien TJ, Lander CM, et al. Changing patterns of antiepileptic drug use in pregnant Australian women. Acta Neurol Scand. 2010;121(2):89\u201393.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"435_CR167","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1535-7511.2008.00273.x","volume":"8","author":"KJ Meador","year":"2008","unstructured":"Meador KJ. Effects of in utero antiepileptic drug exposure. Epilepsy Curr Am Epilepsy Soc. 2008;8(6):143\u20137.","journal-title":"Epilepsy Curr Am Epilepsy Soc."},{"issue":"Suppl 9","key":"435_CR168","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2005.00323.x","volume":"46","author":"P Crawford","year":"2005","unstructured":"Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia. 2005;46(Suppl 9):117\u201324.","journal-title":"Epilepsia."},{"issue":"3","key":"435_CR169","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/adc.66.3.320","volume":"66","author":"SW D\u2019Souza","year":"1991","unstructured":"D\u2019Souza SW, Robertson IG, Donnai D, Mawer G. Fetal phenytoin exposure, hypoplastic nails, and jitteriness. Arch Dis Child. 1991;66(3):320\u20134.","journal-title":"Arch Dis Child"},{"key":"435_CR170","doi-asserted-by":"crossref","unstructured":"Koch S, Jager-Roman E, Losche G, Nau H, Rating D, Helge H. Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome. Acta paediatrica (Oslo, Norway: 1992). 1996;85(6):739\u201346.","DOI":"10.1111\/j.1651-2227.1996.tb14137.x"},{"issue":"2","key":"435_CR171","doi-asserted-by":"crossref","first-page":"F124","DOI":"10.1136\/fn.83.2.F124","volume":"83","author":"F Ebbesen","year":"2000","unstructured":"Ebbesen F, Joergensen A, Hoseth E, Kaad PH, Moeller M, Holsteen V, et al. Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child Fetal Neonatal Ed. 2000;83(2):F124\u20139.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"435_CR172","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(25)32875-2","volume":"219","author":"H Nau","year":"1981","unstructured":"Nau H, Rating D, Koch S, Hauser I, Helge H. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother\u2019s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther. 1981;219(3):768\u201377.","journal-title":"J Pharmacol Exp Ther."},{"key":"435_CR173","doi-asserted-by":"crossref","unstructured":"Thisted E, Ebbesen F. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child. 1993;69(3 Spec No):288\u201391.","DOI":"10.1136\/adc.69.3_Spec_No.288"},{"issue":"4","key":"435_CR174","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/jp.2012.107","volume":"33","author":"SD Duncan","year":"2013","unstructured":"Duncan SD, Devlin LA. Use of baclofen for withdrawal in a preterm infant. J Perinatol. 2013;33(4):327\u20138.","journal-title":"J Perinatol"},{"issue":"7304","key":"435_CR175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.323.7304.85","volume":"323","author":"BD Ratnayaka","year":"2001","unstructured":"Ratnayaka BD, Dhaliwal H, Watkin S. Drug points: Neonatal convulsions after withdrawal of baclofen. BMJ (Clin Res Ed). 2001;323(7304):85.","journal-title":"BMJ (Clin Res Ed)."},{"issue":"7","key":"435_CR176","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2008-1069536","volume":"108","author":"S Koch","year":"1983","unstructured":"Koch S, Gopfert-Geyer I, Jager-Roman E, Jakob S, Huth H, Hartmann A, et al. Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development [in German]. Dtsch Med Wochenschr. 1983;108(7):250\u20137.","journal-title":"Dtsch Med Wochenschr"},{"issue":"6","key":"435_CR177","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pediatrneurol.2013.02.012","volume":"48","author":"A Rolnitsky","year":"2013","unstructured":"Rolnitsky A, Merlob P, Klinger G. In utero oxcarbazepine and a withdrawal syndrome, anomalies, and hyponatremia. Pediatr Neurol. 2013;48(6):466\u20138.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"435_CR178","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0029-1214404","volume":"213","author":"S Vieker","year":"2009","unstructured":"Vieker S, Thiel M, Langler A. Neonatal seizures caused by lamotrigin withdrawal? [in German]. Z Geburtshilfe Neonatol. 2009;213(2):62\u20133.","journal-title":"Z Geburtshilfe Neonatol"},{"issue":"5","key":"435_CR179","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pediatrneurol.2015.06.023","volume":"53","author":"M Carrasco","year":"2015","unstructured":"Carrasco M, Rao SC, Bearer CF, Sundararajan S. Neonatal gabapentin withdrawal syndrome. Pediatr Neurol. 2015;53(5):445\u20137.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"435_CR180","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.ftd.0000179843.63515.8f","volume":"27","author":"T Tomson","year":"2005","unstructured":"Tomson T. Gender aspects of pharmacokinetics of new and old AEDs: pregnancy and breast-feeding. Ther Drug Monit. 2005;27(6):718\u201321.","journal-title":"Ther Drug Monit"},{"key":"435_CR181","unstructured":"Ishizaki T, Yokochi K, Chiba K, Tabuchi T, Wagatsuma T. Placental transfer of anticonvulsants (phenobarbital, phenytoin, valproic acid) and the elimination from neonates. Pediatr Pharmacol (N Y NY). 1981;1(4):291\u2013303."},{"issue":"1","key":"435_CR182","first-page":"153","volume":"17","author":"A Semczuk-Sikora","year":"2010","unstructured":"Semczuk-Sikora A, Czuczwar S, Semczuk A, Kwasniewska A, Semczuk M. Valproic acid transfer across human placental cotyledon during dual perfusion in vitro. Ann Agric Environ Med AAEM. 2010;17(1):153\u20137.","journal-title":"Ann Agric Environ Med AAEM."},{"issue":"10","key":"435_CR183","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1528-1167.2005.00251.x","volume":"46","author":"I Ohman","year":"2005","unstructured":"Ohman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia. 2005;46(10):1621\u20134.","journal-title":"Epilepsia."},{"issue":"3","key":"435_CR184","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000457682","volume":"11","author":"W Kuhnz","year":"1988","unstructured":"Kuhnz W, Koch S, Helge H, Nau H. Primidone and phenobarbital during lactation period in epileptic women: total and free drug serum levels in the nursed infants and their effects on neonatal behavior. Dev Pharmacol Ther. 1988;11(3):147\u201354.","journal-title":"Dev Pharmacol Ther."},{"issue":"3","key":"435_CR185","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1399-5618.2005.00200.x","volume":"7","author":"KT Tran","year":"2005","unstructured":"Tran KT, Hranicky D, Lark T, Jacob N. Gabapentin withdrawal syndrome in the presence of a taper. Bipolar Disord. 2005;7(3):302\u20134.","journal-title":"Bipolar Disord"},{"issue":"6","key":"435_CR186","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1176\/appi.psy.46.6.503","volume":"46","author":"RJ Leo","year":"2005","unstructured":"Leo RJ, Baer D. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics. 2005;46(6):503\u20137.","journal-title":"Psychosomatics."},{"issue":"3","key":"435_CR187","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0143-4179(94)90071-X","volume":"27","author":"M Asai","year":"1994","unstructured":"Asai M, Talavera E, Massarini A, Zubieta M, Vindrola O. Valproic acid-induced rapid changes of met-enkephalin levels in rat brain. Probable association with abstinence behavior and anticonvulsant activity. Neuropeptides. 1994;27(3):203\u201310.","journal-title":"Neuropeptides."},{"issue":"3","key":"435_CR188","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1528-1157.1990.tb05383.x","volume":"31","author":"JS Duncan","year":"1990","unstructured":"Duncan JS, Shorvon SD, Trimble MR. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy. Epilepsia. 1990;31(3):324\u201333.","journal-title":"Epilepsia."},{"issue":"4","key":"435_CR189","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF00644738","volume":"6","author":"B Jalling","year":"1973","unstructured":"Jalling B, Boreus LO, Kallberg N, Agurell S. Disappearance from the newborn of circulating prenatally administered phenobarbital. Eur J Clin Pharmacol. 1973;6(4):234\u20138.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"435_CR190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0022-3476(72)80577-8","volume":"80","author":"MM Desmond","year":"1972","unstructured":"Desmond MM, Schwanecke RP, Wilson GS, Yasunaga S, Burgdorff I. Maternal barbiturate utilization and neonatal withdrawal symptomatology. J Pediatr. 1972;80(2):190\u20137.","journal-title":"J Pediatr."},{"issue":"1","key":"435_CR191","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2011.06.035","volume":"159","author":"AA Zuppa","year":"2011","unstructured":"Zuppa AA, Carducci C, Scorrano A, Antichi E, Catenazzi P, Piras A, et al. Infants born to mothers under phenobarbital treatment: correlation between serum levels and clinical features of neonates. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):53\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"435_CR192","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1684\/epd.2011.0444","volume":"13","author":"LL Zhang","year":"2011","unstructured":"Zhang LL, Zeng LN, Li YP. Side effects of phenobarbital in epilepsy: a systematic review. Epileptic Disord Int Epilepsy J Videotape. 2011;13(4):349\u201365.","journal-title":"Epileptic Disord Int Epilepsy J Videotape."},{"issue":"2","key":"435_CR193","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.1972.03200150049012","volume":"221","author":"WA Bleyer","year":"1972","unstructured":"Bleyer WA, Marshall RE. Barbiturate withdrawal syndrome in a passively addicted infant. JAMA. 1972;221(2):185\u20136.","journal-title":"JAMA"},{"issue":"617","key":"435_CR194","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/pgmj.53.617.157","volume":"53","author":"I Blumenthal","year":"1977","unstructured":"Blumenthal I, Lindsay S. Neonatal barbiturate withdrawal. Postgrad Med J. 1977;53(617):157\u20138.","journal-title":"Postgrad Med J"},{"issue":"5974","key":"435_CR195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bmj.3.5974.40","volume":"3","author":"MJ Erith","year":"1975","unstructured":"Erith MJ. Letter: Withdrawal symptoms in newborn infants of epileptic mothers. Br Med J. 1975;3(5974):40.","journal-title":"Br Med J"},{"key":"435_CR196","doi-asserted-by":"crossref","unstructured":"Neonatal behaviour and maternal barbiturates. Br Med J. 1972;4(5832):63\u20134.","DOI":"10.1136\/bmj.4.5832.63-a"},{"issue":"5","key":"435_CR197","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-0528.1957.tb08460.x","volume":"64","author":"L Ploman","year":"1957","unstructured":"Ploman L, Persson BH. On the transfer of barbiturates to the human foetus and their accumulation in some of its vital organs. J Obstetr Gynaecol Br Emp. 1957;64(5):706\u201311.","journal-title":"J Obstetr Gynaecol Br Emp."},{"issue":"7521","key":"435_CR198","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(67)92593-7","volume":"2","author":"JC Melchior","year":"1967","unstructured":"Melchior JC, Svensmark O, Trolle D. Placental transfer of phenobarbitone in epileptic women, and elimination in newborns. Lancet. 1967;2(7521):860\u20131.","journal-title":"Lancet"},{"key":"435_CR199","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1824-7288-39-50","volume":"39","author":"R Davanzo","year":"2013","unstructured":"Davanzo R, Dal Bo S, Bua J, Copertino M, Zanelli E, Matarazzo L. Antiepileptic drugs and breastfeeding. Ital J Pediatr. 2013;39:50.","journal-title":"Ital J Pediatr."},{"issue":"1","key":"435_CR200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2008.06.014","volume":"18","author":"JM Bidlack","year":"2009","unstructured":"Bidlack JM, Morris HH 3rd. Phenobarbital withdrawal seizures may occur over several weeks before remitting: human data and hypothetical mechanism. Seizure. 2009;18(1):79\u201381.","journal-title":"Seizure."},{"issue":"8821","key":"435_CR201","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0140-6736(92)92232-5","volume":"340","author":"U Bergman","year":"1992","unstructured":"Bergman U, Rosa FW, Baum C, Wiholm BE, Faich GA. Effects of exposure to benzodiazepine during fetal life. Lancet. 1992;340(8821):694\u20136.","journal-title":"Lancet"},{"key":"435_CR202","doi-asserted-by":"crossref","unstructured":"Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatric Serv (Wash, DC). 2002;53(1):39\u201349.","DOI":"10.1176\/appi.ps.53.1.39"},{"key":"435_CR203","doi-asserted-by":"crossref","unstructured":"McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol (Elmsford, NY). 1994;8(6):461\u201375.","DOI":"10.1016\/0890-6238(94)90029-9"},{"key":"435_CR204","first-page":"549","volume":"46","author":"A Addis","year":"2000","unstructured":"Addis A, Dolovich LR, Einarson TR, Koren G. Can we use anxiolytics during pregnancy without anxiety? Can Fam Physician Med Fam Can. 2000;46:549\u201351.","journal-title":"Can Fam Physician Med Fam Can."},{"issue":"3","key":"435_CR205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/FTD.0b013e318288453f","volume":"35","author":"E Lendoiro","year":"2013","unstructured":"Lendoiro E, Gonzalez-Colmenero E, Concheiro-Guisan A, de Castro A, Cruz A, Lopez-Rivadulla M, et al. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy. Ther Drug Monit. 2013;35(3):296\u2013304.","journal-title":"Ther Drug Monit"},{"issue":"11","key":"435_CR206","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","volume":"16","author":"BN Wikner","year":"2007","unstructured":"Wikner BN, Stiller CO, Bergman U, Asker C, Kallen B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16(11):1203\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"435_CR207","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199920020-00006","volume":"20","author":"C McGrath","year":"1999","unstructured":"McGrath C, Buist A, Norman TR. Treatment of anxiety during pregnancy: effects of psychotropic drug treatment on the developing fetus. Drug Saf. 1999;20(2):171\u201386.","journal-title":"Drug Saf"},{"issue":"1","key":"435_CR208","first-page":"90","volume":"22","author":"S Uzun","year":"2010","unstructured":"Uzun S, Kozumplik O, Jakovljevic M, Sedic B. Side effects of treatment with benzodiazepines. Psychiatr Danub. 2010;22(1):90\u20133.","journal-title":"Psychiatr Danub."},{"issue":"4","key":"435_CR209","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/AOG.0b013e31816fd910","volume":"111","author":"ACOG Practice Bulletin","year":"2008","unstructured":"ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 2008;111(4):1001\u201320.","journal-title":"Obstet Gynecol"},{"issue":"7162","key":"435_CR210","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","volume":"317","author":"LR Dolovich","year":"1998","unstructured":"Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ (Clin Res Ed). 1998;317(7162):839\u201343.","journal-title":"BMJ (Clin Res Ed)."},{"issue":"1","key":"435_CR211","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/15563659109038604","volume":"29","author":"P Richard","year":"1991","unstructured":"Richard P, Autret E, Bardol J, Soyez C, Barbier P, Jonville AP, et al. The use of flumazenil in a neonate. J Toxicol Clin Toxicol. 1991;29(1):137\u201340.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"9","key":"435_CR212","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.arcped.2005.03.055","volume":"12","author":"D Swortfiguer","year":"2005","unstructured":"Swortfiguer D, Cissoko H, Giraudeau B, Jonville-Bera AP, Bensouda L, Autret-Leca E. Neonatal consequences of benzodiazepines used during the last month of pregnancy [in French]. Arch Pediatr. 2005;12(9):1327\u201331.","journal-title":"Arch Pediatr"},{"issue":"8","key":"435_CR213","first-page":"213","volume":"64","author":"JN Lind","year":"2015","unstructured":"Lind JN, Petersen EE, Lederer PA, Phillips-Bell GS, Perrine CG, Li R, et al. Infant and maternal characteristics in neonatal abstinence syndrome\u2013selected hospitals in Florida, 2010\u20132011. MMWR Morb Mortal Wkly Rep. 2015;64(8):213\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8048","key":"435_CR214","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(77)90565-7","volume":"2","author":"KA Drury","year":"1977","unstructured":"Drury KA, Spalding E, Donaldson D, Rutherford D. Floppy-infant syndrome: Is oxazepam the answer? Lancet. 1977;2(8048):1126\u20137.","journal-title":"Lancet"},{"issue":"10","key":"435_CR215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/bja\/51.10.971","volume":"51","author":"RJ McBride","year":"1979","unstructured":"McBride RJ, Dundee JW, Moore J, Toner W, Howard PJ. A study of the plasma concentrations of lorazepam in mother and neonate. Br J Anaesth. 1979;51(10):971\u20138.","journal-title":"Br J Anaesth"},{"issue":"3","key":"435_CR216","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000056242","volume":"70","author":"L Weinstock","year":"2001","unstructured":"Weinstock L, Cohen LS, Bailey JW, Blatman R, Rosenbaum JF. Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom. 2001;70(3):158\u201362.","journal-title":"Psychother Psychosom"},{"issue":"5","key":"435_CR217","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0022-3476(65)80375-4","volume":"67","author":"HG Decancq Jr","year":"1965","unstructured":"Decancq HG Jr, Bosco JR, Townsend EH Jr. Chlordiazepoxide in labor. Its effect on the newborn infant. J Pediatrics. 1965;67(5):836\u201340.","journal-title":"J Pediatrics."},{"issue":"8038","key":"435_CR218","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(77)91463-5","volume":"2","author":"K Haram","year":"1977","unstructured":"Haram K. \u201cFloppy infant syndrome\u201d and maternal diazepam. Lancet. 1977;2(8038):612\u20133.","journal-title":"Lancet"},{"issue":"9","key":"435_CR219","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2044.1979.tb08542.x","volume":"34","author":"JS Crawford","year":"1979","unstructured":"Crawford JS. Premedication for elective Caesarean section. Anaesthesia. 1979;34(9):892\u20137.","journal-title":"Anaesthesia."},{"issue":"1","key":"435_CR220","first-page":"46","volume":"186","author":"E Gitsch","year":"1982","unstructured":"Gitsch E, Philipp K, Schonbauer M. Intranatal administration of midazolam (author\u2019s transl). Z Geburtshilfe Perinatol. 1982;186(1):46\u20139.","journal-title":"Z Geburtshilfe Perinatol."},{"issue":"6","key":"435_CR221","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00004714-199412000-00021","volume":"14","author":"RI Shader","year":"1994","unstructured":"Shader RI. Is there anything new on the use of psychotropic drugs during pregnancy? J Clin Psychopharmacol. 1994;14(6):438.","journal-title":"J Clin Psychopharmacol"},{"issue":"8547","key":"435_CR222","first-page":"1436","volume":"1","author":"WS Barry","year":"1987","unstructured":"Barry WS. St Clair SM. Exposure to benzodiazepines in utero. Lancet. 1987;1(8547):1436\u20137.","journal-title":"Exposure to benzodiazepines in utero. Lancet."},{"issue":"7","key":"435_CR223","first-page":"351","volume":"100","author":"S Bitnun","year":"1969","unstructured":"Bitnun S. Possible effect of chlordiazepoxide on the fetus. Can Med Assoc J. 1969;100(7):351.","journal-title":"Can Med Assoc J"},{"issue":"6","key":"435_CR224","first-page":"407","volume":"48","author":"C Bellantuono","year":"2013","unstructured":"Bellantuono C, Orsolini L, Bozzi F. The safety profile of escitalopram in pregnancy and breastfeeding [in Italian]. Riv Psichiatr. 2013;48(6):407\u201314.","journal-title":"Riv Psichiatr."},{"issue":"5","key":"435_CR225","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF01955914","volume":"152","author":"AM Cone","year":"1993","unstructured":"Cone AM, Nadel S, Sweeney B. Flumazenil reverses diazepam-induced neonatal apnoea and hypotonia. Eur J Pediatr. 1993;152(5):458\u20139.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"435_CR226","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0924-9338(96)88396-9","volume":"11","author":"V Michele Di","year":"1996","unstructured":"Di Michele V, Ramenghi L, Sabatino G. Clozapine and lorazepam administration in pregnancy. Eur Psychiatry J Assoc Eur Psychiatr. 1996;11(4):214.","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr."},{"key":"435_CR227","doi-asserted-by":"crossref","unstructured":"Garcia-Algar O, Lopez-Vilchez MA, Martin I, Mur A, Pellegrini M, Pacifici R et al. Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis. Clin Toxicol (Phila, Pa). 2007;45(3):295\u20138.","DOI":"10.1080\/15563650601072191"},{"issue":"8031","key":"435_CR228","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(77)92855-0","volume":"2","author":"C Gillberg","year":"1977","unstructured":"Gillberg C. \u201cFloppy infant syndrome\u201d and maternal diazepam. Lancet. 1977;2(8031):244.","journal-title":"Lancet"},{"issue":"1","key":"435_CR229","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(77)80785-3","volume":"90","author":"JL Rementeria","year":"1977","unstructured":"Rementeria JL, Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatrics. 1977;90(1):123\u20136.","journal-title":"J Pediatrics."},{"issue":"8043","key":"435_CR230","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(77)90817-0","volume":"2","author":"AN Speight","year":"1977","unstructured":"Speight AN. Floppy-infant syndrome and maternal diazepam and\/or nitrazepam. Lancet. 1977;2(8043):878.","journal-title":"Lancet"},{"issue":"3 Suppl","key":"435_CR231","first-page":"34s","volume":"66","author":"JB Fisher","year":"1985","unstructured":"Fisher JB, Edgren BE, Mammel MC, Coleman JM. Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol. 1985;66(3 Suppl):34s\u20135s.","journal-title":"Obstet Gynecol"},{"issue":"48","key":"435_CR232","first-page":"4416","volume":"76","author":"A Rane","year":"1979","unstructured":"Rane A, Sundwall A, Tomson G. Oxazepam withdrawal in the neonatal period [in Swedish]. Lakartidningen. 1979;76(48):4416\u20137.","journal-title":"Lakartidningen."},{"issue":"5","key":"435_CR233","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0002-9378(77)90102-8","volume":"129","author":"E Mazzi","year":"1977","unstructured":"Mazzi E. Possible neonatal diazepam withdrawal: a case report. Am J Obstet Gynecol. 1977;129(5):586\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"435_CR234","first-page":"584","volume":"79","author":"CR Backes","year":"1980","unstructured":"Backes CR, Cordero L. Withdrawal symptoms in the neonate from presumptive intrauterine exposure to diazepam: report of case. J Am Osteopath Assoc. 1980;79(9):584\u20135.","journal-title":"J Am Osteopath Assoc."},{"issue":"2","key":"435_CR235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9378(16)33306-3","volume":"124","author":"P Athinarayanan","year":"1976","unstructured":"Athinarayanan P, Pierog SH, Nigam SK, Glass L. Chloriazepoxide withdrawal in the neonate. Am J Obstet Gynecol. 1976;124(2):212\u20133.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"435_CR236","first-page":"121","volume":"29","author":"J Gonzalez de Dios","year":"1999","unstructured":"Gonzalez de Dios J, Moya-Benavent M, Carratala-Marco F. \u201cFloppy infant\u201d syndrome in twins secondary to the use of benzodiazepines during pregnancy [in Spanish]. Rev Neurol. 1999;29(2):121\u20133.","journal-title":"Rev Neurol."},{"issue":"5921","key":"435_CR237","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.2.5921.729-b","volume":"2","author":"GM Stirrat","year":"1974","unstructured":"Stirrat GM, Edington PT, Berry DJ. Letter: transplacental passage of chlordiazepoxide. Br Med J. 1974;2(5921):729.","journal-title":"Br Med J"},{"issue":"5","key":"435_CR238","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.410110518","volume":"11","author":"RL Kriel","year":"1982","unstructured":"Kriel RL, Cloyd J. Clonazepam and pregnancy. Ann Neurol. 1982;11(5):544.","journal-title":"Ann Neurol."},{"issue":"7\u20138","key":"435_CR239","first-page":"614","volume":"23","author":"PO Anderson","year":"1989","unstructured":"Anderson PO, McGuire GG. Neonatal alprazolam withdrawal\u2013possible effects of breast feeding. DICP Ann Pharmacother. 1989;23(7\u20138):614.","journal-title":"DICP Ann Pharmacother."},{"issue":"6","key":"435_CR240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1742-1241.1972.tb04440.x","volume":"26","author":"RW Shannon","year":"1972","unstructured":"Shannon RW, Fraser GP, Aitken RG, Harper JR. Diazepam in preeclamptic toxaemia with special reference to its effect on the newborn infant. Br J Clin Pract. 1972;26(6):271\u20135.","journal-title":"Br J Clin Pract."},{"issue":"16","key":"435_CR241","first-page":"636","volume":"54","author":"DL Woods","year":"1978","unstructured":"Woods DL, Malan AF. Side-effects of maternal diazepam on the newborn infant. S Afr Med J. 1978;54(16):636.","journal-title":"S Afr Med J"},{"issue":"3","key":"435_CR242","first-page":"305","volume":"36","author":"F Bavoux","year":"1981","unstructured":"Bavoux F, Lanfranchi C, Olive G, Asensi D, Dulac O, Francoual C, et al. Adverse effects on newborns from intra uterine exposure to benzodiazepines and other psychotropic agents (author\u2019s transl). Therapie. 1981;36(3):305\u201312.","journal-title":"Therapie."},{"issue":"1","key":"435_CR243","first-page":"68","volume":"34","author":"CE Flowers","year":"1969","unstructured":"Flowers CE, Rudolph AJ, Desmond MM. Diazepam (valium) as an adjunct in obstetric analgesia. Obstet Gynecol. 1969;34(1):68\u201381.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"435_CR244","first-page":"726","volume":"29","author":"R Nisbet","year":"1967","unstructured":"Nisbet R, Boulas SH, Kantor HI. Diazepam (valium) during labor. Obstet Gynecol. 1967;29(5):726\u20139.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"435_CR245","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1471-0528.1973.tb11206.x","volume":"80","author":"GT McCarthy","year":"1973","unstructured":"McCarthy GT, O\u2019Connell B, Robinson AE. Blood levels of diazepam in infants of two mothers given large doses of diazepam during labour. J Obstetr Gynaecol Br Commonw. 1973;80(4):349\u201352.","journal-title":"J Obstetr Gynaecol Br Commonw."},{"issue":"251","key":"435_CR246","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/adc.47.251.107","volume":"47","author":"JR Owen","year":"1972","unstructured":"Owen JR, Irani SF, Blair AW. Effect of diazepam administered to mothers during labour on temperature regulation of neonate. Arch Dis Child. 1972;47(251):107\u201310.","journal-title":"Arch Dis Child"},{"issue":"5887","key":"435_CR247","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/bmj.4.5887.251","volume":"4","author":"JE Cree","year":"1973","unstructured":"Cree JE, Meyer J, Hailey DM. Diazepam in labour: its metabolism and effect on the clinical condition and thermogenesis of the newborn. Br Med J. 1973;4(5887):251\u20135.","journal-title":"Br Med J"},{"issue":"2","key":"435_CR248","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1471-0528.1982.tb04683.x","volume":"89","author":"DM McAuley","year":"1982","unstructured":"McAuley DM, O\u2019Neill MP, Moore J, Dundee JW. Lorazepam premedication for labour. Br J Obstet Gynaecol. 1982;89(2):149\u201354.","journal-title":"Br J Obstet Gynaecol"},{"issue":"6270","key":"435_CR249","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.282.6270.1106","volume":"282","author":"AG Whitelaw","year":"1981","unstructured":"Whitelaw AG, Cummings AJ, McFadyen IR. Effect of maternal lorazepam on the neonate. Br Med J (Clin Res Ed). 1981;282(6270):1106\u20138.","journal-title":"Br Med J (Clin Res Ed)."},{"issue":"6","key":"435_CR250","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1542\/peds.101.6.1079","volume":"101","author":"Neonatal drug withdrawal","year":"1998","unstructured":"Neonatal drug withdrawal. American Academy of Pediatrics Committee on drugs. Pediatrics. 1998;101(6):1079\u201388.","journal-title":"Pediatrics"},{"issue":"5","key":"435_CR251","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2165\/00003495-198223050-00002","volume":"23","author":"JH Kanto","year":"1982","unstructured":"Kanto JH. Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs. 1982;23(5):354\u201380.","journal-title":"Drugs."},{"issue":"2","key":"435_CR252","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/13556219872227","volume":"3","author":"Z Weintraub","year":"1998","unstructured":"Weintraub Z, Bental Y, Olivan A, Rotschild A. Neonatal withdrawal syndrome and behavioral effects produced by maternal drug use. Addict Biol. 1998;3(2):159\u201370.","journal-title":"Addict Biol"},{"issue":"2","key":"435_CR253","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002130051104","volume":"146","author":"J Potokar","year":"1999","unstructured":"Potokar J, Coupland N, Wilson S, Rich A, Nutt D. Assessment of GABA(A)benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines. Psychopharmacology. 1999;146(2):180\u20134.","journal-title":"Psychopharmacology"},{"issue":"2","key":"435_CR254","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199309020-00003","volume":"9","author":"S Marriott","year":"1993","unstructured":"Marriott S, Tyrer P. Benzodiazepine dependence. Avoidance and withdrawal. Drug Saf. 1993;9(2):93\u2013103.","journal-title":"Drug Saf."},{"issue":"2","key":"435_CR255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1471-0528.1993.tb15221.x","volume":"100","author":"MM Stahl","year":"1993","unstructured":"Stahl MM, Saldeen P, Vinge E. Reversal of fetal benzodiazepine intoxication using flumazenil. Br J Obstet Gynaecol. 1993;100(2):185\u20138.","journal-title":"Br J Obstet Gynaecol"},{"issue":"9","key":"435_CR256","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0895-4356(88)90100-X","volume":"41","author":"B Schmidt","year":"1988","unstructured":"Schmidt B, Kirpalani H, Rosenbaum P, Cadman D. Strengths and limitations of the Apgar score: a critical appraisal. J Clin Epidemiol. 1988;41(9):843\u201350.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"435_CR257","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0447.1980.tb00609.x","volume":"62","author":"O Odegard","year":"1980","unstructured":"Odegard O. Fertility of psychiatric first admissions in Norway 1936\u20131975. Acta Psychiatr Scand. 1980;62(3):212\u201320.","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"435_CR258","first-page":"942","volume":"43","author":"WH Miller Jr","year":"1992","unstructured":"Miller WH Jr, Bloom JD, Resnick MP. Prenatal care for pregnant chronic mentally ill patients. Hosp Community Psychiatry. 1992;43(9):942\u20133.","journal-title":"Hosp Community Psychiatry"},{"key":"435_CR259","unstructured":"Castle DJ, McGrath J, Kulkarni J. Reproductive, preconceptual and antenatal needs of women with schizophrenia. Women and Schizophrenia. Cambridge: Cambridge University Press; 2000."},{"key":"435_CR260","volume-title":"Prescribing guidelines in psychiatry","author":"D Taylor","year":"2012","unstructured":"Taylor D, Paton C, Kapur S. Prescribing guidelines in psychiatry. 11th ed. CornWall: Wiley; 2012.","edition":"11"},{"issue":"5","key":"435_CR261","first-page":"929","volume":"3","author":"DL Torre","year":"2007","unstructured":"Torre DL, Falorni A. Pharmacological causes of hyperprolactinemia. Ther Clin Risk Manag. 2007;3(5):929\u201351.","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"435_CR262","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0447.1984.tb01191.x","volume":"70","author":"TF McNeil","year":"1984","unstructured":"McNeil TF, Kaij L, Malmquist-Larsson A. Women with nonorganic psychosis: pregnancy\u2019s effect on mental health during pregnancy. Acta Psychiatr Scand. 1984;70(2):140\u20138.","journal-title":"Acta Psychiatr Scand"},{"key":"435_CR263","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1192\/bjp.171.1.69","volume":"171","author":"JH Coverdale","year":"1997","unstructured":"Coverdale JH, Turbott SH, Roberts H. Family planning needs and STD risk behaviours of female psychiatric out-patients. Br J Psychiatry J Mental Sci. 1997;171:69\u201372.","journal-title":"Br J Psychiatry J Mental Sci."},{"issue":"1","key":"435_CR264","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1399-5618.2003.00089.x","volume":"6","author":"VK Burt","year":"2004","unstructured":"Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord. 2004;6(1):2\u201313.","journal-title":"Bipolar Disord"},{"key":"435_CR265","doi-asserted-by":"crossref","unstructured":"Swann AC. Special needs of women with bipolar disorder. Intellyst Medical Communication International Congress on Women\u2019s Mental Health; 17\u201320 March 2004; Washington, DC; 2004. p. 4\u201318.","DOI":"10.1017\/S1092852900029047"},{"issue":"1\u20132","key":"435_CR266","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-0327(99)00197-4","volume":"61","author":"P Grof","year":"2000","unstructured":"Grof P, Robbins W, Alda M, Berghoefer A, Vojtechovsky M, Nilsson A, et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord. 2000;61(1\u20132):31\u20139.","journal-title":"J Affect Disord"},{"key":"435_CR267","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1192\/bjp.150.5.662","volume":"150","author":"RE Kendell","year":"1987","unstructured":"Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry J Mental Sci. 1987;150:662\u201373.","journal-title":"Br J Psychiatry J Mental Sci."},{"key":"435_CR268","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM196305302682205","volume":"268","author":"TF Pugh","year":"1963","unstructured":"Pugh TF, Jerath BK, Schmidt WM, Reed RB. Rates of mental disease related to childbearing. N Engl J Med. 1963;268:1224\u20138.","journal-title":"N Engl J Med."},{"issue":"3","key":"435_CR269","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0447.1995.tb09761.x","volume":"91","author":"P Videbech","year":"1995","unstructured":"Videbech P, Gouliaev G. First admission with puerperal psychosis: 7\u201314 years of follow-up. Acta Psychiatr Scand. 1995;91(3):167\u201373.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"435_CR270","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.v63n0403","volume":"63","author":"MP Freeman","year":"2002","unstructured":"Freeman MP, Smith KW, Freeman SA, McElroy SL, Kmetz GE, Wright R, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63(4):284\u20137.","journal-title":"J Clin Psychiatry."},{"issue":"5","key":"435_CR271","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00023210-200721050-00002","volume":"21","author":"S Gentile","year":"2007","unstructured":"Gentile S. Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights. CNS drugs. 2007;21(5):367\u201387.","journal-title":"CNS drugs."},{"issue":"7","key":"435_CR272","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/pds.3366","volume":"22","author":"RA Epstein","year":"2013","unstructured":"Epstein RA, Bobo WV, Shelton RC, Arbogast PG, Morrow JA, Wang W, et al. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf. 2013;22(7):794\u2013801.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"435_CR273","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.pra.0000351878.45260.94","volume":"15","author":"A Einarson","year":"2009","unstructured":"Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract. 2009;15(3):183\u201392.","journal-title":"J Psychiatr Pract."},{"issue":"3","key":"435_CR274","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/schbul\/sbn107","volume":"36","author":"S Gentile","year":"2010","unstructured":"Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull. 2010;36(3):518\u201344.","journal-title":"Schizophr Bull."},{"issue":"3","key":"435_CR275","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","volume":"28","author":"M Reis","year":"2008","unstructured":"Reis M, Kallen B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28(3):279\u201388.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"435_CR276","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","volume":"69","author":"KC Johnson","year":"2012","unstructured":"Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69(8):787\u201394.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"435_CR277","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0892-0362(92)90050-K","volume":"14","author":"JG Auerbach","year":"1992","unstructured":"Auerbach JG, Hans SL, Marcus J, Maeir S. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol. 1992;14(6):399\u2013406.","journal-title":"Neurotoxicol Teratol"},{"key":"435_CR278","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm243903.htm . Accessed 8 June 2016."},{"issue":"5","key":"435_CR279","doi-asserted-by":"crossref","first-page":"e94788","DOI":"10.1371\/journal.pone.0094788","volume":"9","author":"J Kulkarni","year":"2014","unstructured":"Kulkarni J, Worsley R, Gilbert H, Gavrilidis E, Van Rheenen TE, Wang W, et al. A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies. PLoS ONE. 2014;9(5):e94788.","journal-title":"PLoS ONE"},{"key":"435_CR280","doi-asserted-by":"crossref","unstructured":"McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66(4):444\u20139 (quiz 546).","DOI":"10.4088\/JCP.v66n0406"},{"issue":"2","key":"435_CR281","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.pnpbp.2006.09.017","volume":"31","author":"SW Kim","year":"2007","unstructured":"Kim SW, Kim KM, Kim JM, Shin IS, Shin HY, Yang SJ, et al. Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):543\u20135.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"435_CR282","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00048670601172798","volume":"41","author":"K McCauley-Elsom","year":"2007","unstructured":"McCauley-Elsom K, Kulkarni J. Managing psychosis in pregnancy. Aust N Z J Psychiatry. 2007;41(3):289\u201392.","journal-title":"Aust N Z J Psychiatry."},{"issue":"3","key":"435_CR283","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00002018-200730030-00006","volume":"30","author":"D Coppola","year":"2007","unstructured":"Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf. 2007;30(3):247\u201364.","journal-title":"Drug Saf"},{"issue":"3","key":"435_CR284","doi-asserted-by":"crossref","first-page":"F198","DOI":"10.1136\/fn.84.3.F198","volume":"84","author":"Y Nako","year":"2001","unstructured":"Nako Y, Tachibana A, Fujiu T, Tomomasa T, Morikawa A. Neonatal thrombocytosis resulting from the maternal use of non-narcotic antischizophrenic drugs during pregnancy. Arch Dis Child Fetal Neonatal Ed. 2001;84(3):F198\u2013200.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"435_CR285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/bfm.2010.0027","volume":"6","author":"O Gilad","year":"2011","unstructured":"Gilad O, Merlob P, Stahl B, Klinger G. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed Med. 2011;6(2):55\u20138.","journal-title":"Breastfeed Med."},{"key":"435_CR286","first-page":"239","volume-title":"Psychotropic drug directory","author":"S Bazire","year":"2005","unstructured":"Bazire S. Psychotropic drug directory. Salisbury: Fivepin Limited; 2005:239."},{"key":"435_CR287","first-page":"197","volume":"6","author":"VJKP Dev","year":"1995","unstructured":"Dev VJKP. Adverse event profile and safety of clozapine. Rev Contemp Pharmacother. 1995;6:197\u2013208.","journal-title":"Rev Contemp Pharmacother."},{"key":"435_CR288","first-page":"282","volume":"94","author":"LKM Vavrusova","year":"1998","unstructured":"Vavrusova LKM. Clozapine administration during pregnancy [in Czechoslovakian]. Ceska Slov Psychiatr. 1998;94:282\u20135.","journal-title":"Ceska Slov Psychiatr"},{"issue":"7","key":"435_CR289","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4088\/JCP.v64n0718e","volume":"64","author":"DN Mendhekar","year":"2003","unstructured":"Mendhekar DN, Sharma JB, Srivastava PK, War L. Clozapine and pregnancy. J Clin Psychiatry. 2003;64(7):850.","journal-title":"J Clin Psychiatry."},{"issue":"6","key":"435_CR290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2004-832689","volume":"37","author":"H Karakula","year":"2004","unstructured":"Karakula H, Szajer K, Rpila B, Grzywa A, Chuchra M. Clozapine and pregnancy\u2014a case history. Pharmacopsychiatry. 2004;37(6):303\u20134.","journal-title":"Pharmacopsychiatry."},{"issue":"8","key":"435_CR291","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4088\/JCP.v58n0806f","volume":"58","author":"SC Stoner","year":"1997","unstructured":"Stoner SC, Sommi RW Jr, Marken PA, Anya I, Vaughn J. Clozapine use in two full-term pregnancies. J Clin Psychiatry. 1997;58(8):364\u20135.","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"435_CR292","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0020-7292(02)00276-X","volume":"79","author":"Y Yogev","year":"2002","unstructured":"Yogev Y, Ben-Haroush A, Kaplan B. Maternal clozapine treatment and decreased fetal heart rate variability. Int J Gynaecol Obstet. 2002;79(3):259\u201360.","journal-title":"Int J Gynaecol Obstet"},{"key":"435_CR293","doi-asserted-by":"crossref","unstructured":"Biswasl PN, Wilton LV, Pearcel GL, Freemantle S, Shakir SA. The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. J Psychopharmacol (Oxf, Engl). 2001;15(4):265\u201371.","DOI":"10.1177\/026988110101500405"},{"issue":"4","key":"435_CR294","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00004714-200008000-00002","volume":"20","author":"DJ Goldstein","year":"2000","unstructured":"Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol. 2000;20(4):399\u2013403.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"435_CR295","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5694\/j.1326-5377.1981.tb135684.x","volume":"1","author":"M O\u2019Connor","year":"1981","unstructured":"O\u2019Connor M, Johnson GH, James DI. Intrauterine effect of phenothiazines. Med J Aust. 1981;1(8):416\u20137.","journal-title":"Med J Aust."},{"issue":"7","key":"435_CR296","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1176\/ajp.134.7.815","volume":"134","author":"MF Cleary","year":"1977","unstructured":"Cleary MF. Fluphenazine decanoate during pregnancy. Am J Psychiatry. 1977;134(7):815\u20136.","journal-title":"Am J Psychiatry."},{"issue":"1","key":"435_CR297","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/106002809603000106","volume":"30","author":"SP Nath","year":"1996","unstructured":"Nath SP, Miller DA, Muraskas JK. Severe rhinorrhea and respiratory distress in a neonate exposed to fluphenazine hydrochloride prenatally. Ann Pharmacother. 1996;30(1):35\u20137.","journal-title":"Ann Pharmacother."},{"issue":"8","key":"435_CR298","first-page":"36","volume":"2","author":"MM Iqbal","year":"2005","unstructured":"Iqbal MM, Aneja A, Rahman A, Megna J, Freemont W, Shiplo M, et al. The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation. Psychiatry. 2005;2(8):36\u201344.","journal-title":"Psychiatry."},{"issue":"8","key":"435_CR299","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","volume":"164","author":"DJ Newport","year":"2007","unstructured":"Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164(8):1214\u201320.","journal-title":"Am J Psychiatry."},{"issue":"11","key":"435_CR300","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1176\/ajp.135.11.1321","volume":"135","author":"G Gardos","year":"1978","unstructured":"Gardos G, Cole JO, Tarsy D. Withdrawal syndromes associated with antipsychotic drugs. The American journal of psychiatry. 1978;135(11):1321\u20134.","journal-title":"The American journal of psychiatry."},{"issue":"11","key":"435_CR301","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1176\/ajp.137.11.1395","volume":"137","author":"DJ Luchins","year":"1980","unstructured":"Luchins DJ, Freed WJ, Wyatt RJ. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs. Am J Psychiatry. 1980;137(11):1395\u20138.","journal-title":"Am J Psychiatry."},{"issue":"9870","key":"435_CR302","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(13)60671-6","volume":"381","author":"R Worsley","year":"2013","unstructured":"Worsley R, Gilbert H, Gavrilidis E, Naughton B, Kulkarni J. Breastfeeding and psychotropic medications. Lancet. 2013;381(9870):905.","journal-title":"Lancet"},{"issue":"2\u20133","key":"435_CR303","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0378-3782(88)80014-8","volume":"17","author":"MJ Boutroy","year":"1988","unstructured":"Boutroy MJ, Gisonna CR, Legagneur M. Clonidine: placental transfer and neonatal adaption. Early Human Dev. 1988;17(2\u20133):275\u201386.","journal-title":"Early Human Dev"},{"key":"435_CR304","doi-asserted-by":"crossref","unstructured":"Prenner BM. Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride. Am J Dis Child (1960). 1977;131(5):529\u201330.","DOI":"10.1001\/archpedi.1977.02120180043007"},{"key":"435_CR305","doi-asserted-by":"crossref","unstructured":"Serreau R, Komiha M, Blanc F, Guillot F, Jacqz-Aigrain E. Neonatal seizures associated with maternal hydroxyzine hydrochloride in late pregnancy. Reprod Toxicol (Elmsford, NY). 2005;20(4):573\u20134.","DOI":"10.1016\/j.reprotox.2005.03.005"},{"issue":"1","key":"435_CR306","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-3782(01)00232-8","volume":"66","author":"M Shimohira","year":"2002","unstructured":"Shimohira M, Iwakawa Y, Kohyama J. Rapid-eye-movement sleep in jittery infants. Early Human Dev. 2002;66(1):25\u201331.","journal-title":"Early Human Dev"},{"issue":"9168","key":"435_CR307","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(99)00306-2","volume":"353","author":"M South","year":"1999","unstructured":"South M. Neonatal seizures after use of pyridoxine in pregnancy. Lancet. 1999;353(9168):1940\u20131.","journal-title":"Lancet"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0435-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-016-0435-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0435-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T21:28:14Z","timestamp":1748986094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-016-0435-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":307,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1007\/s40264-016-0435-8","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}